SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

Teva Raises 2026 Outlook After 33% Growth in Key Brands

Teva said its neuroscience portfolio is expanding through the Weltruza launch and the addition of BXCL-501.

TEVA

Related stories